LONDON BROKER RATINGS: UBS raises Michael Page to 'buy'
(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday: Read More
| Price | 885.00p on 28-08-2026 at 08:54:16 |
|---|---|
| Change | 5.00p 0.57% |
| Buy | 886.00p |
| Sell | 885.00p |
| Last Trade: | Sell 388.00 at 885.00p |
| Day's Volume: | 17,447 |
| Last Close: | 880.00p |
| Open: | 883.00p |
| ISIN: | GB0000961622 |
| Day's Range | 883.00p - 888.00p |
| 52wk Range: | 580.00p - 973.00p |
| Market Capitalisation: | £4.17b |
| VWAP: | 884.78987p |
| Shares in Issue: | 470.79m |
Balfour Beatty (BBY) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 388 | 885.00p | Automatic Execution |
09:54:01 - 28-Aug-26 |
| Sell* | 27 | 885.00p | Automatic Execution |
09:54:01 - 28-Aug-26 |
| Buy* | 2 | 885.50p | Automatic Execution |
09:53:34 - 28-Aug-26 |
| Sell* | 2 | 885.407p | SI Trade |
09:46:56 - 28-Aug-26 |
| Buy* | 5 | 885.50p | Automatic Execution |
09:43:45 - 28-Aug-26 |
| Unknown* | 0 | 886.00p | SI Trade |
09:41:15 - 28-Aug-26 |
| Sell* | 244 | 885.00p | Automatic Execution |
09:40:05 - 28-Aug-26 |
| Sell* | 4 | 885.00p | SI Trade |
09:40:04 - 28-Aug-26 |
| Sell* | 342 | 885.432p | SI Trade |
09:38:45 - 28-Aug-26 |
| Sell* | 24 | 885.50p | Automatic Execution |
09:38:21 - 28-Aug-26 |
Balfour Beatty (BBY) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 24th Aug 2026 7:10 am | RNS | Transaction in Own Shares |
| 17th Aug 2026 7:10 am | RNS | Transaction in Own Shares |
| 12th Aug 2026 7:00 am | RNS | BALFOUR BEATTY 2026 HALF YEAR RESULTS |
| 10th Aug 2026 7:10 am | RNS | Transaction in Own Shares |
| 3rd Aug 2026 7:10 am | RNS | Total Voting Rights |
| 3rd Aug 2026 7:10 am | RNS | Transaction in Own Shares |
| 27th Jul 2026 7:49 am | RNS | Transaction in Own Shares |
| 20th Jul 2026 7:10 am | RNS | Transaction in Own Shares |
| 13th Jul 2026 7:10 am | RNS | Transaction in Own Shares |
| 8th Jul 2026 3:23 pm | RNS | Director/PDMR Shareholding |